調査・レポート

Pharmacy-reported drug safety cases can reveal new signals and support pharmacovigilance, especially for outpatients and OTC drugs, presented at the 2026 KPA symposium.

A Korean survey on medication error experiences and reporting in community pharmacies was praised for its policy and practical value at the 84th FIP World Congress in Montreal.

In a phase‑3 trial, first‑line sacituzumab govitecan combined with pembrolizumab numerically extended PFS in high PD‑L1 metastatic NSCLC but did not meet pre‑specified statistical significance, nor improve OS versus pembrolizumab alone.

A Korean study found that siblings of pediatric type‑1 diabetes patients have more than ten times the risk compared with the general child population, highlighting the importance of early detection.

A joint UCSF and Rush University study of 2,603 women found that earlier menopause is associated with accelerated cognitive decline and earlier onset of Alzheimer’s disease.

US researchers found that older adults with strong psychological resilience experience fewer health symptoms in later life, based on a study of 4,466 participants.

AbbVie’s Qulipta (atogepant) reduced migraine days versus placebo in a Phase 3 menstrual migraine study, meeting the primary endpoint and supporting label expansion.

After a cold, lingering cough and phlegm result from airway inflammation and hyper‑reactive receptors; the article examines how bronchial health ingredients may address these symptoms.

Research confirms boswellic acids, especially AKBA, in Boswellia serrata resin as effective anti‑inflammatory agents for arthritis treatment.

Korean pharmacies commonly use Maekmundong‑tang, Maheong‑gamseok‑tang, Cheongpae‑tang and Cheongsang‑bohwan for cough. Maekmundong‑tang is preferred when phlegm is scant and dry‑cough triggers are present.

Depression and sleep‑disorder cases each exceeded 1 million last year, with anxiety over 910 k; patient numbers have risen steadily, urging stronger mental‑health measures.

GC Cell presented data from a retrospective study showing that ImmuneCell LC may increase disease‑free and overall survival in HCC patients beyond Milan criteria who received liver transplants.